arBtrage CAPITALIZING MARKETS checking… Sign in

REGENXBIO Inc.

RGNX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$6.08
▼ -11.6% Today
as of Jun 7, 07:26 ET
Last 30 days -30.03% Apr 28 → Jun 05
$5.26 $6.68 $8.10 $9.52 $10.94 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$6.83
High
$6.91
Low
$6.00
Volume
$2M
Avg Vol
$861,153
Mkt Cap
$356M
P/E (TTM)
Beta
52w High
$16.19
52w Low
$5.46
Div Yield
Shares Out
$52M

Overview

52-week range
$5.46
$16
6% of range
Avg surprise (last 2)
-48.6%
Avg reaction (last 2)
-15.9%
50% positive
Latest IV / EM
101%
EM ±14.0% · $6 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.72$-1.19$-0.66$-0.12$0.41 Actual $-1.66Actual $-1.41Actual $-1.38Actual $-1.05Actual $-1.17Actual $0.12Est $0.41Actual $-1.38Actual $-1.20Actual $-1.72Est $-1.36 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-90M$-66M$-42M$-18M$6M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-1.72 $-1.36 -26.5% -1,533% -37.8% earnings
Tue Sep 30, 2025Sep 2025 $-1.20 financials
Mon Jun 30, 2025Jun 2025 $-1.38 financials
Mon May 12, 2025Mar/2025 $0.12 $0.41 -70.7% +6.0% earnings
Mon Sep 30, 2024Sep 2024 $-1.17 financials
Sun Jun 30, 2024Jun 2024 $-1.05 financials
Sun Mar 31, 2024Mar 2024 $-1.38 financials
Sat Sep 30, 2023Sep 2023 $-1.41 financials
Fri Jun 30, 2023Jun 2023 $-1.66 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$12M$11M
Gross profit
Operating income$-83M$-52M$-63M$12M$-62M$-56M
Net income$-90M$-62M$-71M$6M$-60M$-53M
EPS (diluted)$-1.72$-1.20$-1.38$0.12$-1.17$-1.05

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$15M$34M$59M$80M$130M$58M$57M$58M
Inventory
Total current assets$187M$281M$332M$374M$313M$278M$313M$347M
Total assets$342M$453M$525M$581M$491M$466M$519M$569M
Long-term debt
Total liabilities$321M$350M$364M$367M$217M$206M$218M$221M
Total equity$21M$103M$161M$214M$274M$260M$301M$348M

Implied volatility — last 90 days

95%98%100%103%105% Jun 07 — IV 101% · EM ±14.0%

Sector peers